STERIS plc (NYSE:STE) Shares Acquired by Benjamin Edwards Inc.

Benjamin Edwards Inc. raised its holdings in STERIS plc (NYSE:STE - Free Report) by 1.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 114,861 shares of the medical equipment provider's stock after purchasing an additional 1,189 shares during the quarter. Benjamin Edwards Inc. owned 0.12% of STERIS worth $23,614,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Avalon Trust Co acquired a new stake in shares of STERIS in the fourth quarter valued at $30,000. Human Investing LLC acquired a new position in STERIS in the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC grew its position in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after buying an additional 91 shares during the last quarter. Central Pacific Bank Trust Division increased its position in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after purchasing an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC raised its position in STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after purchasing an additional 137 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

STERIS Stock Up 1.3 %

Shares of STE traded up $2.96 during midday trading on Wednesday, reaching $225.41. 755,566 shares of the company were exchanged, compared to its average volume of 541,228. The company has a market cap of $22.15 billion, a price-to-earnings ratio of 47.86 and a beta of 0.96. STERIS plc has a 1-year low of $200.98 and a 1-year high of $248.24. The stock has a 50-day moving average price of $223.19 and a 200-day moving average price of $218.78. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Research analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Tuesday, June 10th will be paid a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.01%. STERIS's dividend payout ratio (DPR) is 48.41%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Stephens upgraded shares of STERIS to a "strong-buy" rating in a research report on Thursday, May 1st. Piper Sandler increased their price target on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. JMP Securities reiterated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a report on Thursday, April 10th. Finally, Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research note on Monday, April 7th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Buy" and an average target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.